Send me a link:

*Text messaging rates may apply.

 Dow Up0.36% Nasdaq Up0.71%

Synta Pharmaceuticals Corp. (SNTA)

-NasdaqGM
4.15 0.08(1.97%) Jul 22, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development17,583  19,981  17,623  17,876  
Selling General and Administrative5,324  3,463  4,171  4,187  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (22,907) (23,444) (21,794) (22,063)
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -   -  
Earnings Before Interest And Taxes(22,907)(23,444)(21,794)(22,063)
Interest Expense650  718  721  724  
Income Before Tax(23,557)(24,162)(22,515)(22,787)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(23,557)(24,162)(22,515)(22,787)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (23,557) (24,162) (22,515) (22,787)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (23,557) (24,162) (22,515) (22,787)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.